Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis.

Reisler RB, Gibbs PH, Danner DK, Boudreau EF.

Vaccine. 2012 Nov 26;30(50):7271-7. doi: 10.1016/j.vaccine.2012.09.049. Epub 2012 Sep 29.

PMID:
23031498
2.

Free clinics: a personal journey: comment on "Free clinics in the United States".

Gibbs RD, Gibbs PH.

Arch Intern Med. 2010 Jun 14;170(11):953-4. doi: 10.1001/archinternmed.2010.132. No abstract available.

PMID:
20548007
3.

Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity.

Reisler RB, Danner DK, Gibbs PH.

Vaccine. 2010 Mar 11;28(12):2436-41. doi: 10.1016/j.vaccine.2009.12.080. Epub 2010 Jan 8.

PMID:
20060946
4.

Immune interference after sequential alphavirus vaccine vaccinations.

Pittman PR, Liu CT, Cannon TL, Mangiafico JA, Gibbs PH.

Vaccine. 2009 Aug 6;27(36):4879-82. doi: 10.1016/j.vaccine.2009.02.090. Epub 2009 Mar 11.

PMID:
19576665
5.

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.

Rusnak JM, Byrne WR, Chung KN, Gibbs PH, Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS, Rezvani DF, Huggins JW.

Antiviral Res. 2009 Jan;81(1):68-76. doi: 10.1016/j.antiviral.2008.09.007. Epub 2008 Oct 31. Erratum in: Antiviral Res. 2009 Jul;83(1):99-100.

PMID:
18977392
6.

Whole-body plethysmography in African green monkeys (Chlorocebus aethiops) with and without jackets.

Foster CD, Hunter TC, Gibbs PH, Leffel EK.

J Am Assoc Lab Anim Sci. 2008 Sep;47(5):52-5.

7.

Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.

Treviño SR, Permenter AR, England MJ, Parthasarathy N, Gibbs PH, Waag DM, Chanh TC.

Infect Immun. 2006 Mar;74(3):1958-61.

8.

Long-term health effects of repeated exposure to multiple vaccines.

Pittman PR, Coonan KM, Gibbs PH, Scott HM, Cannon TL, McKee KT Jr.

Vaccine. 2004 Dec 9;23(4):525-36.

PMID:
15530702
9.
10.

Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.

Boles JW, Pitt ML, LeClaire RD, Gibbs PH, Torres E, Dyas B, Ulrich RG, Bavari S.

Clin Immunol. 2003 Jul;108(1):51-9.

PMID:
12865071
11.

Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule.

Boles JW, Pitt ML, LeClaire RD, Gibbs PH, Ulrich RG, Bavari S.

Vaccine. 2003 Jun 20;21(21-22):2791-6.

PMID:
12798619
12.
13.

Anthrax vaccine: short-term safety experience in humans.

Pittman PR, Gibbs PH, Cannon TL, Friedlander AM.

Vaccine. 2001 Dec 12;20(5-6):972-8.

PMID:
11738765
14.

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.

Fellows PF, Linscott MK, Ivins BE, Pitt ML, Rossi CA, Gibbs PH, Friedlander AM.

Vaccine. 2001 Apr 30;19(23-24):3241-7. Erratum in: Vaccine 2001 Nov 12;20(3-4):635.

PMID:
11312020
15.

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans.

Pittman PR, Mangiafico JA, Rossi CA, Cannon TL, Gibbs PH, Parker GW, Friedlander AM.

Vaccine. 2000 Sep 15;19(2-3):213-6.

PMID:
10930675
16.

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ.

Vaccine. 1999 Aug 20;18(1-2):181-9.

PMID:
10501248
17.

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.

Ivins BE, Pitt ML, Fellows PF, Farchaus JW, Benner GE, Waag DM, Little SF, Anderson GW Jr, Gibbs PH, Friedlander AM.

Vaccine. 1998 Jul;16(11-12):1141-8.

PMID:
9682372
18.

Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.

Maiztegui JI, McKee KT Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ.

J Infect Dis. 1998 Feb;177(2):277-83.

PMID:
9466512
19.

Steady-state minute volume determination by body-only plethysmography in juvenile rhesus monkeys.

Besch TK, Ruble DL, Gibbs PH, Pitt ML.

Lab Anim Sci. 1996 Oct;46(5):539-44.

PMID:
8905587
20.
21.

Exposure variables in bancroftian filariasis in the Nile Delta.

Gad AM, Feinsod FM, Soliman BA, Nelson GO, Gibbs PH, Shoukry A.

J Egypt Soc Parasitol. 1994 Aug;24(2):439-55.

PMID:
8077763
23.

Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response.

Morrill JC, Jennings GB, Johnson AJ, Cosgriff TM, Gibbs PH, Peters CJ.

Arch Virol. 1990;110(3-4):195-212.

PMID:
1690534
24.

Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys.

Cosgriff TM, Morrill JC, Jennings GB, Hodgson LA, Slayter MV, Gibbs PH, Peters CJ.

Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S807-14.

PMID:
2749112
25.

Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha.

Morrill JC, Jennings GB, Cosgriff TM, Gibbs PH, Peters CJ.

Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S815-25.

PMID:
2546250
26.

Reduced survival of adult Culex pipiens infected with Rift Valley fever virus.

Faran ME, Turell MJ, Romoser WS, Routier RG, Gibbs PH, Cannon TL, Bailey CL.

Am J Trop Med Hyg. 1987 Sep;37(2):403-9.

PMID:
3661832
27.

Patient understanding of commonly used medical vocabulary.

Gibbs RD, Gibbs PH, Henrich J.

J Fam Pract. 1987 Aug;25(2):176-8. No abstract available.

PMID:
3612043
28.

Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials.

Meadors GF 3rd, Gibbs PH, Peters CJ.

Vaccine. 1986 Sep;4(3):179-84.

PMID:
3532605
29.

Differences in susceptibility of inbred mice to Bacillus anthracis.

Welkos SL, Keener TJ, Gibbs PH.

Infect Immun. 1986 Mar;51(3):795-800.

30.

Variation in responsiveness of BALB/c sublines and congenic mice to phase I Coxiella burnetii infection and vaccination.

Williams JC, Sanchez V, Scott GH, Stephenson EH, Gibbs PH.

Curr Top Microbiol Immunol. 1985;122:189-99. No abstract available.

PMID:
4042676

Supplemental Content

Loading ...
Support Center